Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Osteoporos Int. 2016 Nov 3;28(1):169–178. doi: 10.1007/s00198-016-3811-4

Figure 2.

Figure 2

Prescription rates of any anti-osteoporosis medication after primary hip fracture by geographical region during 1999-2004 (2a) and during 2005-13 (2b) within the Clinical Practice Research Datalink, UK

Legend: This figure shows for each time period, the proportion of patients alive and followed up within CPRD receiving a prescription of anti-osteoporosis medication.